Skip to main content
Log in

Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis

  • Inflammation and Immunomodulation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Summary

In vivo anaphylaxis is associated with respiratory distress and cardiovascular failure. The present investigation was designed to further characterize respiratory and cardiac anaphylactic events. In guinea pigs, sensitization was produced by subcutaneous application of ovalbumin together with Freund's adjuvant. Fourteen days after sensitization, the effects of an intravenous infusion of ovalbumin were tested in the anesthetized artificially ventilated guinea pigs. The renewed application of the antigen induced an initial increase of left ventricular pressure which was followed by a rapid decrease 5 min after antigenic challenge. Enddiastolic left ventricular pressure increased within 3 min, thus indicating left ventricular pump failure. In the same time range, ECG recordings uniformly showed signs of acute myocardial ischemia. In addition, heart rate steadily decreased. All animals died within 15 min. Simultaneously with cardiac anaphylactic malfunction, severe arterial hypoxia and carbon dioxide retention occurred, revealing respiratory distress.

Histamine is known as a potent bronchoconstrictor via histamine H1-receptor stimulation. Administration of H1-recpetor antagonists to improve respiration may therefore provide further information on the contribution of pulmonary malfunction to anaphylactic cardiovascular shock. Therefore, additional experiments were performed with sensitized guinea pigs pretreated with the histamine H1-receptor blocker mepyramine. In these experiments the antigenic challenge induced a dissociation of cardiac and respiratory manifestation of anphylaxis. Despite inhibition of hypoxia and carbon dioxide retention, left ventricular pump failure and occurrence of myocardial ischemia were delayed but not suppressed.

It is concluded that histamine is an important mediator of anaphylactic respiratory distress. However, vasoactive anaphylactic mediators other than histamine are primarily involved in anaphylactic cardiac malfunction occurring during the later phase of systemic anaphylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. K. Greeff, B. G. Benfey and A. Bokelmann,Anaphylaktische Reaktionen am isolierten Herzvorhofpräparat des Meerschweinchens und ihre Beeinflussung durch Antihistaminika, BOL, Dihydroergotamin und Reserpin. Naunyn-Schmiedeberg's Arch. Exp. Path. Pharmakol.236, 421–434 (1959).

    Google Scholar 

  2. G. A. Feigen and D. J. Prager,Experimental cardiac anaphylaxis. Physiologic, pharmacologic and biochemical aspects of immune reactions in the isolated heart. Am. J. Cardiol.24, 474–491 (1969).

    Article  PubMed  Google Scholar 

  3. R. Levi,Effect of exogenous and immunologically released histamine on the isolated heart: A quantitative comparison. J. Pharmacol. Exp. Ther.182, 227–238 (1972).

    PubMed  Google Scholar 

  4. R. Levi,Cardiac anaphylaxis: Models, mediators, mechanisms, and clinical considerations. InHuman inflammatory disease, clinical immunology. Vol. 1, pp. 93–105 (eds. G. Marone, L. M. Lichtenstein, M. Condorelli, A. S. Fauci). B. C. Decker, Inc., Toronto 1988.

    Google Scholar 

  5. N. Capurro and R. Levi,The heart as a target organ in systemic allergic reactions. Comparison of cardiac anaphylaxis in vivo and in vitro. Circ. Res.36, 520–528 (1975).

    PubMed  Google Scholar 

  6. E. T. Nishimura, R. Patterson, J. N. Fink and J. N. Wennemark,Myocardial lesions associated with experimental passive transfer of immediate type hypersensitivity. Lab. Invest.15, 1269–1278 (1966).

    PubMed  Google Scholar 

  7. R. Patterson, J. N. Fink, J. Wennemark, J. Baum, J. Pruzansky and E. T. Nishimura,The biologic consequences of the immediate type hypersensitivity transferred from man to monkey. J. Allergy37, 295–310 (1966).

    PubMed  Google Scholar 

  8. S. B. Felix, G. Baumann and W. E. Berdel,Systemic anaphylaxis — separation of cardiac reactions from respiratory and peripheral vascular events. Res. Exp. Med.190, 239–252 (1990).

    Google Scholar 

  9. W. Lorenz and A. Doenicke,H 1 and H 2 Blockade: A prophylactic principle in anesthesia and surgery against histamine-release responses of any degree of severity: Part I. N. Engl. Res. Allerg. Proc.6, 38–57 (1985).

    Google Scholar 

  10. W. Lorenz and A. Doenicke,H 1 and H 2 Blockade: A prophylactic principle in anesthesia and surgery against histamine-release responses of any degree of severity: Part II. N. Engl. Res. Allerg. Proc.6, 174–192 (1985).

    Google Scholar 

  11. J. Joad and T. B. Casale,Histamine and airway caliber. Ann. Allergy.61, 1–7 (1988).

    Google Scholar 

  12. G. Neumann, W. Erhardt, B. Oberhuber, R. Fritsch and G. Blümel,A new highly potent and short-acting analgesic, Carfentanyl (R33799) in combination with the hypnotic agent Etomidat (R26490), as a method of analgesia in guinea pigs. Res. Exp. Med.177, 135–143 (1980).

    Article  Google Scholar 

  13. K. Pavek, A. Wegmann, L. Nordström and D. Schwander,Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin. Wochenschr.60, 941–947 (1982).

    Article  PubMed  Google Scholar 

  14. H. J. Silvermann, C. Van Hook and E. F. Haponik,Hemodynamic changes in human anaphylaxis. Am. J. Med.77, 341–344 (1984).

    Article  PubMed  Google Scholar 

  15. R. F. Raper and M. McD. Fisher,Profound reversible dial depression after anaphylaxis. Lancet1, 386–388 (1988).

    Article  PubMed  Google Scholar 

  16. B. H. Booth and R. Patterson:Electrocardiographic changes during human anaphylaxis. J.A.M.A.211, 627–631 (1970).

    PubMed  Google Scholar 

  17. L. H. Criep and T. R. Woehler,The heart in human anaphylaxis. Ann. Allergy29, 399–409 (1971).

    PubMed  Google Scholar 

  18. H. D. Levine,Acute myocardial infarction following wasp sting: report of two cases and critical survey of the literature. Am. Heart J.91, 365–374 (1976).

    PubMed  Google Scholar 

  19. M. N. Druck, D. E. Johnstone, H. Staniloff and P. R. McLaughlin,Coronary artery spasm as a manifestation of anaphylactoid reaction to iodinated contrast material. Can. Med. Assoc. J.125, 1133–1135 (1981).

    PubMed  Google Scholar 

  20. D. Antonelli, B. Koltun and J. Barzilay,Transient ST segment elevation during anaphylactic shock. Am. Heart J.108, 1052–1054 (1984).

    Article  PubMed  Google Scholar 

  21. E. S. K. Assem,Anaphylactic reactions affecting the human heart. Agents and Actions27, 142–145 (1989).

    PubMed  Google Scholar 

  22. R. Levi, N. Capurro and C.-H. Lee,Pharmacological characterization of cardiac histamine receptors: sensitivity to H 1-and H2-receptors agonists and antagonists. Eur. J. Pharmacol.30, 328–335 (1975).

    Google Scholar 

  23. J. H. McNeil and S. C. Verma,Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate. J. Pharmacol. Exp. Ther.188, 180–188 (1974).

    PubMed  Google Scholar 

  24. G. Baumann, S. B. Felix, J. Schrader, C. D. Heidecke, G. Riess, W. D. Erhardt, L. Ludwig, U. Loher, F. Sebening and H. Blömer,Cardiac contractile and metabolic effects mediated via the myocardial H 2-receptor adenylate cyclase system. Res. Exp. Med.179, 81–98 (1981).

    Article  Google Scholar 

  25. M. R. Bristow, R. Ginsburg and D. C. Harrison,Histamine and the human heart: The other receptor system. Am. J. Cardiol.49, 249–251 (1982).

    Article  PubMed  Google Scholar 

  26. G. R. Hageman, F. Urthaler, J. H. Isobe and T. N. James,Chronotropic and dromotropic effects of histamine on the canine heart. Chest75, 597–604 (1979).

    PubMed  Google Scholar 

  27. G. Baumann, U. Loher, S. B. Felix, C. D. Heidecke, G. Riess, L. Ludwig and H. Blömer,Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease. Res. Exp. Med.180, 209–213 (1982).

    Article  Google Scholar 

  28. R. Ginsburg, M. R. Bristow, K. Davis, A. Dibiase and M. E. Billingham,Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation69, 430–440 (1984).

    PubMed  Google Scholar 

  29. C. A. Tozzi, S. G. Dorrell and G. F. Merril,Evidence of histamine-induced myocardial ischemia: reversal by chlorpheniramine and potentiation by atherosclerosis. Cardiovasc. Res.19, 744–753 (1985).

    PubMed  Google Scholar 

  30. N. Toda,Mechanism of histamine actions in human coronary arteries. Circ. Res.61, 280–286 (1987).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grant Fe 250/1-1 from the Deutsche Forschungsgemeinschaft (DFG).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Felix, S.B., Baumann, G., Hashemi, T. et al. Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis. Agents and Actions 33, 349–358 (1991). https://doi.org/10.1007/BF01986585

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01986585

Keywords

Navigation